Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma

In this report, a panel of European myeloma experts discuss the role of pomalidomide in the treatment of relapsed and refractory multiple myeloma (RRMM). Based on the available evidence, the combination of pomalidomide and low-dose dexamethasone is a well-tolerated and effective treatment option for...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Dimopoulos, M A, Leleu, X, Palumbo, A, Moreau, P, Delforge, M, Cavo, M, Ludwig, H, Morgan, G J, Davies, F E, Sonneveld, P, Schey, S A, Zweegman, S, Hansson, M, Weisel, K, Mateos, M V, Facon, T, Miguel, J F S
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2014
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4131249/
https://ncbi.nlm.nih.gov/pubmed/24496300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2014.60
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars